US Patent 11660311 Cyclic dinucleotides as anticancer agents
Patent 11660311 was granted and assigned to Bristol-Myers Squibb on May, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11660311 Cyclic dinucleotides as anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
